Christopher Rogan

Head of Department

Chris O'Brien Lifehouse

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Rogan is the Head of Department at Chris O'Brien Lifehouse in Australia. His research areas encompass interventional radiology, vascular surgery, and oncology, with a focus on treatment methodologies for various tumors and conditions. Recent articles include studies on the use of cyanoacrylates in vascular treatments and the outcomes of selective internal radiation therapy for hepatocellular carcinoma, reflecting his commitment to advancing quality care guidelines and innovative therapeutic techniques.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

David Connor

University of New South Wales

AUSTRALIA

View details

Amany Zekry

AUSTRALIA

View details

Bergthor Björnsson

Linköping University

SWEDEN

View details

Nicholas Brown

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Rogan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents

Is Size All That Matters? New Predictors of Complications and Bleeding in Renal Angiomyolipoma

Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysis.

Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study.

Quality care guidelines for uterine artery embolisation in women with symptomatic uterine fibroids in Australia and New Zealand: According to the <scp>AGREE‐II</scp> checklist and endorsed by the Interventional Radiology Society of Australasia

Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases.

LIPIODOL reduces the lytic activity of detergent sclerosants <i>in vitro</i>.

Endovascular management of recurrent hemarthrosis of the knee: a case series.

Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology

Collaborators (4)

David Connor

Amany Zekry

Bergthor Björnsson

Nicholas Brown

Make your next move.